Search

Displaying results 3501 - 3510 of 6076 in total
  1. Drug

    Naftopidil

    go.drugbank.com/drugs/DB12092
    Investigational

    Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.

  2. Drug

    MK-0557

    go.drugbank.com/drugs/DB12168
    Investigational

    MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.

  3. Drug

    BMS-863233

    go.drugbank.com/drugs/DB12357
    Investigational

    BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.

  4. Drug

    Oglemilast

    go.drugbank.com/drugs/DB12375
    Investigational

    Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

  5. Drug

    Lisofylline

    go.drugbank.com/drugs/DB12406
    Investigational

    Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.

  6. Drug

    Methyl pyrrolidone

    go.drugbank.com/drugs/DB12521
    Investigational

    N Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.

  7. Drug

    GSK-1292263

    go.drugbank.com/drugs/DB12627
    Investigational

    GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.

  8. Drug

    Edivoxetine

    go.drugbank.com/drugs/DB09184
    Investigational

    Edivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012. … Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant

  9. Drug

    UB-612

    go.drugbank.com/drugs/DB16444
    Investigational

    In rats, toxicity studies have so far shown favourable safety for this vaccine[L30653, L30658], Phase 1 trial is currently ongoing in Taiwan (NCT04545749). … In addition, the vaccine contains a proprietary peptide UBITh®1a for enhanced immunogenicity, five identified peptides with Th or CTL epitopes to improve peptide solubility, and aluminum phosphate adjuvant

  10. Drug

    Solanezumab

    go.drugbank.com/drugs/DB11756
    Investigational

    Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.